Arialys Presents Promising Data for IgG1 Antibody Treatment
21 Jun 2025 //
FIERCE BIOTECH
Arialys Shows ART5803 Efficacy In Autoimmune Disorder
17 Jun 2025 //
BUSINESSWIRE
Arialys Starts MAD Cohorts In Ph 1 Study For Autoimmune Disease
26 Feb 2025 //
BUSINESSWIRE
Arialys Appoints Sankalp Gokhale As Chief Medical Officer
22 Oct 2024 //
BUSINESSWIRE
Arialys Therapeutics Doses First Participants In ART5803 Trial
10 Oct 2024 //
BUSINESSWIRE
Arialys Therapeutics Appoints Peter Flynn, Ph.D., as President and CEO
25 Jun 2024 //
BUSINESSWIRE
Arialys Therapeutics Launches to Lead the Development of New Precision Medicines
12 Sep 2023 //
BUSINESSWIRE